Evidence map›Paper›PMID 41066318›Full record

ArticlePloS one2025

Identifying graft incompatible rootstocks for sweet cherry through machine learning algorithms.

Erol Aydın, Mehmet Ali Cengiz, Ercan Er, Hüsnü Demirsoy

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erol AydınDepartment of Horticulture, Black Sea Agricultural Research Institute, Gelemen, Samsun, Türkiye.ORCID https://orcid.org/0000-0002-2710-4075
Mehmet Ali CengizDepartment of Mathematics and Statistics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Ercan ErDepartment of Horticulture, Black Sea Agricultural Research Institute, Gelemen, Samsun, Türkiye.
Hüsnü DemirsoyDepartment of Horticulture, Faculty of Agriculture, Ondokuz Mayıs University, Atakum, Samsun, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graft incompatibility is a key factor in the development of dwarf and semi dwarf rootstocks for sweet cherry (Prunus avium L.) to improve yield, fruit quality, precocity, and labor efficiency. This study evaluated the graft incompatibility of eight genotypes three sweet cherry, three sour cherry, and two mahaleb collected from Northern Anatolia, a native region for cherries. These genotypes, along with standard rootstocks Gisela 6 and SL 64, were grafted with '0900 Ziraat' and 'Lambert' cultivars. Graft incompatibility was assessed using a multidisciplinary approach combining classical morphological and anatomical evaluations with advanced data driven analyses. Parameters such as graft bud growth rate (40.26-86.21%), shoot length (41.01-91.28 cm), and rootstock/scion diameter ratio (0.41-0.92) were measured 12 months after grafting. Principal Component Analysis, Random Forest modeling with SHAP values, and Bayesian ranking were applied to identify key traits and rank genotype performance. The integrated analysis successfully distinguished compatible rootstock candidates, identifying five genotypes with high compatibility potential. These findings demonstrate that combining traditional phenotypic evaluation methods with machine learning-based approaches offers a robust and comprehensive framework for addressing graft incompatibility, and contributes valuable insights for future breeding programs and rootstock selection strategies in sweet cherry.

Indexed as

Machine LearningPlant RootsPrunus aviumAlgorithmsBayes TheoremGenotypePlant BreedingPrincipal Component Analysis

Identifiers

PMID41066318
PMCPMC12510556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.